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Abstract
Background: Phospholipase C (PLC) is an enzyme that plays pivotal role in a number of signaling cascades. These are active
in the plasma membrane and triggers cellular responses by catalyzing the hydrolysis of membrane phospholipids and
thereby generating the secondary messengers. Phosphatidylinositol-PLC (PI-PLC) specifically interacts with phosphoino-
sitide and/or phosphoinositol and catalyzes specific cleavage of sn-3- phosphodiester bond. Several isoforms of PLC are
known to form and function as dimer but very little is known about the molecular basis of the dimerization and its
importance in the lipid interaction.
Principal Findings: We herein report that, the disruption of disulphide bond of a novel PI-specific PLC of C. reinhardtii
(CrPLC) can modulate its interaction affinity with a set of phospholipids and also the stability of its dimer. CrPLC was found
to form a mixture of higher oligomeric states with monomer and dimer as major species. Dimer adduct of CrPLC
disappeared in the presence of DTT, which suggested the involvement of disulphide bond(s) in CrPLC oligomerization.
Dimer-monomer equilibrium studies with the isolated fractions of CrPLC monomer and dimer supported the involvement of
covalent forces in the dimerization of CrPLC. A disulphide bridge was found to be responsible for the dimerization and Cys7
seems to be involved in the formation of the disulphide bond. This crucial disulphide bond also modulated the lipid affinity
of CrPLC. Oligomers of CrPLC were also captured in in vivo condition. CrPLC was mainly found to be localized in the plasma
membrane of the cell. The cell surface localization of CrPLC may have significant implication in the downstream regulatory
function of CrPLC.
Significance: This study helps in establishing the role of CrPLC (or similar proteins) in the quaternary structure of the
molecule its affinities during lipid interactions.
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Introduction
Phosphoinositide (PIP3) has been shown to affect a great variety
of cellular responses, including exocytosis, cytoskeleton remodel-
ing, chemotaxis and regulation of ion channels [1], and its
metabolism inside the cell is stringently controlled [2]. Phospho-
inositide-specific phospholipase C (PI-PLC) is the class of enzymes
that hydrolyzes the highly phosphorylated phosphatidylinositol 4,
5-bisphosphate [PI(4,5)P2], generating two intracellular products
inositol 1,4,5-trisphosphate (InsP3) and diacylglycerol (DAG) [3].
This event serves as one of the earliest key steps to trigger further
phosphoinositide-mediated intracellular signal transduction path-
ways [4]. InsP3 is a universal calcium-mobilizing secondary
messenger [5] and DAG is an activator of protein kinase C [6,7].
Both signaling molecules modulate intracellular Ca
2+ level.
Activated protein kinase C regulates a wide variety of downstream
effectors [8]. PLCs are soluble and membrane associated multi-
domain proteins that are classified into different isoforms like b, c,
d, f, g and e, on the basis of their primary structure and
mechanism of their activation [9]. PLCs harboring single domain
also exist in nature [10]. Different domains of PLC constitutes
catalytic a/b barrel including X and Y region, which represents
the incomplete TIM (triose phosphate isomerase) barrel fold,
hydrophobic rim region, X/Y-spanning sequence (Z Region),
pleckstrin homology (PH) domain, EF-hands, C2 domain and C-
terminus extension [11]. These modular domains of PLCs are
known to regulate lipid interaction and/or enzyme activity
[12,13,14,15].
Dimerization is one of the known molecular behaviours of
phospholipases, which also plays a role in regulation of PLC
activity. Some isoforms of PLC are known to exist and function as
dimers, such as purified PLC from human platelets [16]. In 1994,
Banno et. al. suggested that size exclusion chromatography purified
PLC-b-dimers are catalytically active enzymes [17]. Crystal
structure of avian PLC-b reveals that C-tail is composed of three
long helices, forming a coiled-coil structure, which controls
dimerization of the enzyme in an antiparallel orientation [18].
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39258Figure 1. Homology analysis of PI-PLC isozymes from different organisms. Sequences of Phospholipase C from different organisms
including Chlamydomonas reinhatdtii (CrPLC), Drosophila melanogaster (DmPLC), Arabidopsis thaliana (AtPLC), Homo sapiens (HsPLC), and Mus
musculus (MmPLC) were compared. Identical amino acid residues are represented in white with black background and residues with greater than
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responsible for dimerization, which possesses only the catalytic XY
domain of PLC and also forms a dimer [19,20].
The role of PLC in the unicellular, biflagellate, fresh water alga,
Chlamydomonas reinhardtii has been investigated during stress
responses [21]. In 1992, Quarmby et. al. also demonstrated the
role of PLC in biochemical pathways that couples deflagellation
process, induced by the pH shock [22]. However, there is no
molecular characterization of the phospholipase from C. reinhardtii.
In this study, for the first time we report quaternary structure
characterizations, and identify an important disulphide bridge that
modulates dimer stability and alters lipid interaction affinity of the
novel phospholipase C of Chlamydomonas reinhardtii (CrPLC).
CrPLC possesses only catalytic (XY) and C2 domains. The
quaternary structure characterization of CrPLC suggests that it
exists as dimer in both in vitro and in vivo conditions. Immunolo-
calization studies with CrPLC antibody indicate its association
with plasma membrane in the Chlamydomonas cells.
Results and Discussion
Bioinformatics Analysis of the Novel Phospholi Pase from
C. reinhardtii
Conserved domain analysis of the CrPLC protein sequence
(501a.a) suggested the presence of catalytic domain and the C2
domain. Catalytic domain was found to have a significant
similarity with that of the eukaryotic phosphoinositide-specific
phospholipase C family, which are characterized by the presence
of two well conserved histidine residues (H47 and H88) in the
catalytic domain. Cluster of hydrophobic amino acid residues,
which are responsible in substrate recognition, calcium binding
and catalysis of PI-specific PLC [23] were also found to be
conserved in CrPLC. These residues includes H47, N48, L69,
E77, D79, H88, F110, E122, K164, K166, R286, Y288 and W292
in CrPLC. Domain architecture analysis of CrPLC revealed the
presence of catalytic domain that constitutes conserved X and Y
regions separated by a linker region and calcium binding C2
domain. Comparison of the deduced amino acid sequence of
CrPLC with the other known PLC sequences showed that the
conserved residues are mainly present in the catalytic domain and
C2 domain (Figure 1). Phylogenetic analysis of CrPLC with the
other known phospholipase suggested its close relatedness to
phospholipases present in higher plants. Protein sequence align-
ment showed overall 45% homology with Arabidopsis thaliana
phospholipase (Figures 1 and S1). Predicted tertiary structure of
CrPLC resembled an incomplete triose phosphate isomerase
(TIM) a/b-barrel structural fold. Catalytic domain in 3-D
structure model exhibited alternating a-helices and b-strands
whereas calcium binding C2 domain had five antiparallel b-
strands arranged as a sandwich. Most of the aromatic amino acid
residues including Tyr and Trp present in the tertiary structure of
CrPLC was present on the surface of molecule (Figure S2). Thus,
overall architecture of the tertiary structure of CrPLC would set an
acceptable confirmation of the conserved aromatic rings for
further molecular interactions. It could also establish strong
hydrophobic interaction with residues from the other CrPLC
molecule. CYSPRED server that utilizes the evolutionary infor-
mation for prediction of disulphide bonding state of the cysteine,
predicted that only Cys7 of CrPLC was in bonded state i.e., likely
to participate in the disulphide bond formation whereas other
cysteine residues were in non-bonded state (Free State). According
to Plant-mPLoc analysis, CrPLC was predicted to be localized in
cell membrane. This prediction suggested a possible role of CrPLC
in phosphatidylinositol 4, 5-bisphosphate (PIP2) metabolism and
lipid signaling pathways in the cell.
Recombinant CrPLC Stays as Monomer and Oligomer in
Solution
The cDNA of CrPLC (1503 bp) was isolated, sequenced and
nucleotide sequence encoding CrPLC deposited in GenBank
(Accession number JN052078). Recombinant CrPLC was ex-
pressed mainly in soluble form and purification level was
monitored by SDS-PAGE (Figure S3). CrPLC purified to
homogeneity by size exclusion chromatography (SEC) indicated
that it was eluted in two fractions (Figure 2A). As determined by
calibration of the column with proteins of known molecular
standard, fractions 22–25 (elution volume 67–76 ml) eluted at a
molecular mass of 110 kDa that corresponded to the apparent
molecular mass of CrPLC dimer while fractions 26–29 (elution
volume 79–88 ml) corresponded to the molecular mass of CrPLC
monomer (55 kDa) (Figure S4). A smaller shoulder observed
towards the left of the dimer peak was attributed to the little
amount of higher oligomer of CrPLC. Oligomerization in some
proteins is known to be affected by dilution (concentration
dependent oligomerization) [24]. However, no effect of dilution
was observed on dimerization under varying concentration (5 mM
to 50 mM) of CrPLC using gel filtration analytical column
(Figure 2B). It has also been shown that enzyme activity of some
phospholipases was modulated by reversible dimerization of
enzyme [25,26]. To assess the monomer-dimer equilibrium of
CrPLC, eluted monomer and dimer fractions were reloaded on
the preparatory SEC column and eluents were analyzed
separately. Reloading of CrPLC monomer and dimer fractions
of CrPLC resulted in slight shifting of the monomer elution peaks
towards dimer fraction indicating that the purified monomer
fraction of CrPLC could form dimer, however no conversion of
dimer fraction into monomer was observed, this suggested the
existence of a very high-energy barrier between these states
(Figures 2C and D) CrPLC monomer was found to form dimer
under oxidative conditions, which was not affected by protein
dilution, this implied the involvement of strong covalent forces in
stabilization of CrPLC dimer.
CrPLC Dimerization is Stabilized by Disulphide Bond in
Both in vitro and in vivo Conditions
Dimerization of recombinant CrPLC was interesting in the light
of the fact that phospholipase dimers are known to form functional
complexes. Previous studies suggested the role of dimerization as
the molecular mechanism by which functional role of phospho-
lipases were regulated inside the cell [25]. Chemical crosslinking of
CrPLC using glutaraldehyde crosslinking agent, captured dimer of
CrPLC as observed on SDS-PAGE (data not shown). Immuno-
blotting of chemically cross-linked monomer and dimer fractions
using CrPLC specific antibody showed that the monomer fraction
was present in both monomer and dimer forms, whereas the dimer
fraction was found to be completely cross-linked (dimer). CrPLC
dimer in vivo condition was also determined by similar protein
85% similarity in sequences are highlighted in black with grey background. Residues present in the X–Y domain and catalytic domain are indicated by
black and grey solid bars respectively. Catalytically important and conserved amino acid residues for substrate binding are marked by solid black
circles.
doi:10.1371/journal.pone.0039258.g001
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was cross-linked and CrPLC was probed using specific antibody.
Interestingly, by glutaraldehyde crosslinking of Cr TCL, we were
able to detect both CrPLC dimer and monomer forms. The
formation of higher oligomer was also observed in in vivo
conditions, which could be due to some degree of nonspecific
crosslinking (Figure 3B). Thus, our findings suggested that CrPLC
exist as dimer in both in vitro and in vivo conditions. Various non-
covalent forces and covalent interactions like disulphide bridges
are known to play a role in the formation and stabilization of the
quaternary structure of the proteins. To explore the primary
driving force involved in the stabilization of quaternary structure
of CrPLC, effect of reducing and non-reducing conditions were
compared simultaneously. In SDS-PAGE, CrPLC migrated
predominantly as a dimer of molecular weight 110 kDa under
non-reducing conditions. This higher molecular weight band
totally disappeared under reducing conditions and CrPLC was
detected as a monomer of 55 kDa only (data not shown).
Immunoblotting of SEC purified monomer and dimer peak
fractions (elution volume 70 and 82 ml respectively) under
reducing and non-reducing conditions also showed the presence
of dimer under non reducing conditions (Figure 3C). Small
amount of higher oligomers were also detected by immunoblotting
under non reducing condition (Figure 3C). Moreover, size
exclusion chromatography with 5 mM DTT in the elution buffer
resulted in elimination of the dimer peak (Figure 3D). To find out
the involvement of disulphide bond(s) in native CrPLC, CrPLC
was probed in the Chlamydomonas total cell protein by immuno-
blotting under both reducing and non-reducing conditions.
Similar to that of recombinant CrPLC, under non-reducing
conditions, both monomer and dimer were detected, whereas in
the presence of DTT, dimer completely disappeared (Figure 3E).
Thus, disulphide bonds were found to contribute significantly in
CrPLC dimerization in the native protein as well.
Cys 7 Plays Key Role in CrPLC Dimerization
Disappearance of CrPLC dimer under reducing conditions,
both in vitro and in vivo and the presence of eight cysteine residues
in CrPLC protein sequence provided strong basis for inferring the
involvement of disulphide bridge(s) in CrPLC dimerization.
Moreover, bioinformatics analysis also suggested the existence of
Cys7 residue in a bonded state. Hence, to investigate cysteine
residues involved in the formation of disulphide bond in CrPLC,
the most exposed cysteine residues, present at the N-terminal
sequence (C7), catalytic domains (C68, C73) as well as C2 domain
(C325 and C428) were mutated to alanine. The chromatographic
data representing the elution profile of all CrPLC mutants were
overlaid with the wild type (Figure 4A). As presented earlier, wild
type CrPLC eluted as two major peaks of approximately equal
ratio. In case of C7A mutant, the peak of dimer was found to be
dramatically reduced and CrPLC C7A eluted as a monomer. SEC
profile of C325A and C428A CrPLC were found to be similar to
that of wild type protein. C68A and C73A double mutant formed
higher oligomers with relatively less dimeric form. Immunoblot-
ting of the corresponding elution fractions of CrPLC C7A mutant
when compared with that of wild type and other mutants, showed
Figure 2. Quaternary structures of recombinant CrPLC. (A) Size exclusion chromatogram of recombinant CrPLC. Straight line depicts the
calibration of standard molecular weight marker including, thyroglobulin (670 kDa), c-globulin (158 kDa), ovalbumin (44 kDa), myoglobin (17 kDa)
and vitamin B12 (1.35 kDa). (B) Size-exclusion profile of CrPLC of various concentrations. Elution profiles of CrPLC corresponding to various
concentrations of recombinant CrPLC (5, 10 and 50 mM) were recorded using analytical grade size exclusion chromatography column and shown in
different line patterns as mentioned in the inset of figure. (C and D) Size exclusion chromatogram of reloaded monomer and dimer fractions using
preparatory grade chromatography column are shown in black, overlaid with chromatogram of CrPLC (dotted line).
doi:10.1371/journal.pone.0039258.g002
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and B). The elution fractions of other CrPLC mutants including
C68/73A, C325A and C428A have not shown considerable effect
on dimerization (Figures S5C–E). These findings implied the
importance of Cys7 mediated disulphide bond in the dimerization
of CrPLC.
Cys7 Mutation in CrPLC also Affects Lipid Affinity
It has been proposed for few PI-PLC, that dimerization on the
membrane surface could affect the affinity for its phospholipid
substrate [27]. Similarly, the existence of CrPLC in dimerized
form in Chlamydomonas could have implications for its interaction
with phospholipid substrates. In order to characterize the
functional significance of monomer and dimer species of CrPLC,
lipid interaction of affinity purified recombinant CrPLC (wild type
and mutants) and SEC purified monomer and dimer fractions
were performed by lipid overlay experiments [15,28], respectively.
CrPLC WT that possess both monomer and dimer form showed
association with a set of phospholipids (PIP) such as PI3P, PI4P,
PI5P, PI(3,4)P2, PI(3,5) P2, PI94,5)P2, PI(3,4,5)P2 and PA with
varying binding affinities (Figure 5B). Interestingly, CrPLC C7A
mutant, which is mainly a monomer showed comparatively higher
binding affinity with a set of PIPs when compared with the wild
type CrPLC (Figures 5B and C). Since, C7A mutant showed
significantly increased affinity with PIPs as compared with that of
wild type CrPLC (Figure 5D), binding affinity of the dimer and
monomer fractions of the wild type CrPLC were also compared
(Figures 5E and F). Wild type CrPLC monomer showed binding
with the same set of PIPs but with the much lower affinity
(Figures 5E and G). The dimer fraction of WT CrPLC showed
poorest lipid binding affinity (Figures 5F and G). These results
suggested that the C7A mutant monomeric form potentiate the
binding affinity of CrPLC to a set of PIPs. These results have left
no doubt that the formation of disulphide bond and/or
dimerization poses steric hinderance to some residues and prevents
them from interacting with the set of PIPs. These results further
implied that the process of dimerization might sterically hinder
positively charged amino acid residues from interacting with
negatively charged phospholipids head groups and hence the
dimerization was found to possess lower lipid affinity and mutation
in Cys7 residue which disrupted the dimer, had the highest lipid
affinity.
Figure 3. CrPLC dimerizes both in vitro and in vivo. (A) Immunoblotting of crosslinked (Glutaraldehyde; GA) dimer and monomer peak fractions.
Numbers above each lane are the elution volume in ml with 70 ml (dimer peak fraction) and 82 ml (monomer peak fraction). (B) Cellular detection of
CrPLC dimer and monomer species by glutaraldehyde (GA) crosslinking of Chlamydomonas total cell protein (Cr TCL) followed by immunoblotting. (C)
Immunoblot analysis of CrPLC dimer and monomer peak fractions of size exclusion chromatography in both presence (reducing) and absence (non-
reducing) of dithiothreitol (DTT). (D) Comparative chromatogram of recombinant CrPLC performed under reducing condition using 5 mM DTT (black)
and in non-reducing condition (red). (E) Cellular detection of CrPLC in Cr TCL under reducing and non-reducing conditions. Dimer and Monomer in
the blots are marked as D and M respectively.
doi:10.1371/journal.pone.0039258.g003
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C. reinhardtii
Phospholipase has been proposed to function at the plasma
membrane for regulation of different signaling cascades [29,30].
Overall, cellular localization of CrPLC in C. reinhardtii cell
displayed the preferential localization of CrPLC to the plasma
membrane (Figures 6A and B). Labeling of the cells with the
membrane tracer FM 4-64 (Figure 6C) suggested the co-
localization of CrPLC with the plasma membrane and sub-
cellular membrane vesicle compartment. This preferential
localization might be due to high lipid affinity of CrPLC. Co-
localization of CrPLC with the membrane of sub-cellular
compartment does not rule out the possibility of translocation
of CrPLC protein via sub-cellular membrane vesicle compart-
ments to the plasma membrane. The co-localization signal of
CrPLC with the membrane periphery and absence of such signal
with preimmune serum or in autofluorescence images, confirmed
its association mainly with the plasma membrane (Figures 6D–
G). Membrane association of CrPLC could be essential for C.
reinhardtii cell as it provides its access and availability to
interacting partners. It is required to elucidate the functional
importance of cellular localization of CrPLC after which the
importance of the localization in the plasma membrane may
become more obvious.
Figure 4. Cys7 plays critical role in CrPLC dimer stabilization. (A) Chromatogram of different CrPLC mutants indicated in different colors,
overlaid with wild type CrPLC (CrPLC WT) shown in black. (B) SDS-PAGE analysis of eluents obtained at 70 ml and 82 ml with preparatory size
exclusion chromatography of CrPLC WT and CrPLC C7A mutant under reducing (+DTT) and non-reducing (2DTT) conditions, respectively. (C and D)
Immunoblot analysis of CrPLC WT and CrPLC C7A mutant protein respectively, under reducing (+DTT) and non-reducing (2DTT) conditions. Lanes are
labeled by elution volume of monomer and dimer peak fractions obtained by preparatory size exclusion chromatography. M denotes the marker.
doi:10.1371/journal.pone.0039258.g004
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and its Variants
Secondary structure of the CrPLC WT (WT monomer, WT
dimer and WT monomer and dimer mixture; 1:1) and C7A
mutant were experimentally determined by CD spectroscopy.
Three independent far-UV CD spectroscopy experiments were
performed. CD spectra of variants of CrPLC WT and C7A
mutant between 190 and 260 nm showed strong minimum near
222 nm. CD spectra of CrPLC WT monomer, CrPLC WT dimer
and CrPLC C7A mutant were compared. All the proteins were
well folded and their secondary structure content including
percentage alpha-helicity, turns and random coil content re-
mained largely unchanged (Figures 7A and B). Quantification of
secondary structure content of CrPLC variants were performed
using Raussean et al [31] method, which utilizes experimental data
points of the CD spectra to estimate secondary structure, such
Figure 5. Interaction and affinity of CrPLC with phospholipids. (A) Schematic representation of PIP strip indicating the phospholipid present
in each dot numbered from 1–16. Nomenclature of different phospholipids spotted on membrane are Lysophosphatidic acid (LPA),
lysophosphatidylcholine (LPC), phosphatidylinositol (PtdIns), PtdIns(3)P, PtdIns(4)P, PtdIns(5)P, phosphatidylethanolamine (PE), 8-phosphatidylcholine
(PC), sphingosine 1-phosphate, PtdIns(3,4)P2, PtdIns(3,5)P2, PtdIns(4,5)P2, PtdIns(3,4,5)P3, phosphatidic acid (PA), phosphatidylserine (PS), blank. (B
and C) Lipid overlay using affinity purified CrPLC WT and CrPLC C7A mutant respectively. (D) Bar graph representing the densitometric measurement
of binding of CrPLC WT and C7A mutant (E and F) Comparison of lipid binding affinity of the SEC purified monomer and dimer fractions, respectively.
(G) Bar graph representing the densitometric measurement of binding of monomer and dimer fractions of SEC purified wild type CrPLC. Results
represent the mean 6 standard deviation of three independent experiments.
doi:10.1371/journal.pone.0039258.g005
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content with that of predicted alpha helical component from the
calculated tertiary structure model of CrPLC. Moreover, results
obtained suggested that there is no significant change in the alpha
helical content of the WT monomer (28.2%), WT dimer (26.9%)
and monomer of C7A mutant (28.5%). There was a significant
change in the content of beta sheet of the C7A mutant (19.7%)
compared to that of WT monomer (22.2%). This difference might
account for the minor conformational changes that may impact
binding affinity of CrPLC to the set of PIPs.
Conclusions
Disulphide bridges are known to play important roles in
maintaining the structure of proteins and might regulate function
of the proteins. This study provides strong evidences for the
existence of a novel phospholipase from C. reinhardtii (CrPLC) as
both monomer and dimer forms under physiological and in vitro
conditions. In both the conditions, the disulphide linkages were
found to promote dimerization. Our findings showed the
importance of disulphide bridges in CrPLC dimerization. Three
single mutants (C7A, C325A and C428A) and one double mutant
C68/73A were generated for studying the role of cysteine in
oligomerization and lipid interactions. Mutation C7A was mainly
found to disrupt the dimerization in CrPLC whereas other
mutants like C325A, C428A or C68/73A were not found to affect
the CrPLC dimer but leading to the formation of higher oligomers
of CrPLC protein. C7A mutation disrupted ,95% of dimerization
of CrPLC leading to the increase of monomer fraction of CrPLC
by ,2-fold and formation of small amount of higher oligomers.
Thus, mutational analysis suggested the pivotal role of Cys7 in
CrPLC dimer formation and stabilization. Moreover, substitution
of Cys7 to alanine also altered the affinity of CrPLC for a set of
phospholipids (substrates). Cys7 mutant potentiates the interaction
of CrPLC towards a set of PIPs. However, monomer fraction of
CrPLC wild type protein bound weakly and dimer fraction
showed the poorest lipid interaction to the same set of PIPs. These
experiments left no doubt that Cys7 mutation in CrPLC can
potentiate the phospholipid interaction of CrPLC It would be
interesting to carry out further studies to delineate the functional
importance of the cellular localization of Cr.PLC in Chlamydomonas.
Materials and Methods
Bioinformatic Analysis
Putative CrPLC sequence of C. reinhardtii was fetched from its
genome database (http://www.genome.jgi-psf.org/chlamy). Con-
served domain architecture of CrPLC was analyzed by CDART
program (http://www.ncbi.nlm.nih.gov/Structure/lexington/
lexington.cgi) [32]. PLC sequences from different organisms were
retrieved from NCBI and aligned using CLUSTALW multiple
alignment tool (http://www.ebi.ac.uk/Tools/clustalw2/index.
html ) for homology analysis [33]. Tertiary structure of CrPLC
was predicted using homology modeling program (http://
swissmodel.expasy.org/) and pdb files were viewed on PyMol.
The predicted structure was verified using SAVES tool (http://
nihserver.mbi.ucla.edu/SAVES/) and submitted to protein model
database (PM0077883) [34]. Amino acid residues were located
and highlighted in the tertiary structure model using PyMol
program. Phylogenetic analysis was performed using MEGA
version 5 [35]. Bonded Cysteines were predicted using CysPred
server [36] and subcellular localization of CrPLC protein was
predicted by Plant-mPLoc web-server [37].
Heterologous Expression and Site Directed Mutagenesis
of CrPLC
EST encoding CrPLC (accession number BP094257) was
procured from Kajusa DNA research institute, Japan. A polynu-
cleotide sequence that corresponds to CrPLC was PCR amplified
with forward and reverse 59-ATTGAATTCATGGG-
CAACGTGTTCAGCT-39 and 59-TTACTC-
GAGCTTGGGCCCGGCGTACAT-39 primers respectively us-
ing EST as a template. Amplicon was cloned into pET21a (+)
vector (Novagen, USA) that possess C-terminus hexa-histidine tag.
Point mutations were created using the QuickChange mutagenesis
kit (Stratagene, USA) and verified by automated DNA sequencing.
CrPLC-pET21a was transformed into BL21 (DE3l) E. coli cells.
Cells were grown in terrific broth medium at 37uC and induced
Figure 6. Cellular localization of CrPLC. (A) CrPLC localizes in the plasma membrane of C. reinhardtii cell as shown by green channel (B)
Magnified image of a single cell. (C) Plasma membrane traced by using FM4-64 tracker dye is shown in red. (D) Merged image represent the overlay,
where green and red channels are merged together to confirm CrPLC localization in the plasma membrane. (E) Cells visualized in DIC mode of light
microscopy. (F and G) Immunolocalization with pre-immune serum and auto-fluorescence served as negative control.
doi:10.1371/journal.pone.0039258.g006
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expression was carried out at 16uC for 48 hrs. Recombinant
proteins were purified by immobilized metal affinity chromatog-
raphy using Co
2+ metal ion resins (Clontech, Laboratories Inc.
USA) according to manufacturer’s protocol.
Chlamydomonas Culture and Cell Homogenate
Preparation
C. reinhardtii strain cc 124 mt (2) used in this study was obtained
from Chlamydomonas resource center (Department of Plant Biology,
University of Minnesota). Culture was grown on TAP (tris-acetate
phosphate media, pH 7.4 and supplemented with Hutners trace
elements) at 25uC in an incubator shaker (120 rpm) with
continuous exposure of fluorescent white light (2300 Lux). Cells
in early exponential growth phase were used for all the
experiments. Chlamydomonas total cell lysate (Cr TCL) was prepared
by suspending cells in phosphate buffer saline (PBS; 150 mM
NaCl, 10 mM sodium phosphate, and pH 7.2) in presence of
protease inhibitor cocktail. Cell lysis was performed by sonication,
giving 8 sec on and 8 sec off pulse for 6–8 times. Samples were
solubilized by incubating crude lysate with 263% SDS Laemmli
buffer for 30 min at 60uC.
Size-exclusion Chromatography
Size exclusion chromatography was performed with a Akta
explorer chromatography system (GE Healthcare USA) on
HiLoad 16/60 Superdex 200 (1.0630 cm) prep grade column
and superose 12 10/300 GL analytical grade column, using FPLC
mode, equilibrated with PBS, operated with flow rate of 1 ml/min
at 4uC. Monomer and dimer species were determined by
comparing it with standard molecular weight marker (Bio-Rad,
USA), separated under the isocratic conditions. The peaks in the
chromatogram were fit to a Gaussian curve with the IGOR Pro
program (Wave Metrics Inc.’s).
Western Blotting
Protein blotted nitrocellulose membrane was blocked using 5%
non-fat dry milk powder in PBS supplemented with 0.1% tween-
20 for 1 hr at room temperature. Blocked nitrocellulose mem-
brane was then incubated with primary antibody generated
against recombinant CrPLC at a 1:3000 dilution. Immunolabel-
ling was detected by using HRP (horseradish peroxidase)
conjugated anti-rabbit secondary antibody (1:5000 dilution) and
visualized by enhanced chemiluminiscence method using the
standard protocol.
Figure 7. Secondary structure analysis of CrPLC. (A) Comparision of Far UV-CD spectra recorded for dimer and monomer fractions of CrPLC WT,
CrPLC C7A mutant and equimolar fractions of mixed dimer and monomer CrPLC represented in different line patterns as indicated in inset. (B) Bar
graph represent the calculated percentage secondary structure content including a-helix, b-sheets, turns and random coil content in CrPLC WT
(monomer, dimer and dimer : monomer 1:1) and CrPLC C7A mutant.
doi:10.1371/journal.pone.0039258.g007
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Protein crosslinking was performed by using 2.5% (v/v) freshly
prepared glutaraldehyde (Sigma). 25 mM of heterologously
expressed CrPLC or total cell protein of C. reinhardtii dissolved in
60 ml of PBS was incubated with 5 ml of 2.5% glutaraldehyde at
37uC. Reactions were stopped after 5 min by adding 1 M Tris-Cl,
pH 8. Crosslinked protein samples were resolved on 10% SDS-
PAGE and detected by immunoblotting.
Immunolocalization of CrPLC in Chlamydomonas
Cells in early log phase were harvested and resuspended in PBS.
Aliquots of approximately 200 ml of cell suspension were seeded on
acid washed coverslips and fixed with 3.7% paraformaldehyde in
PBS. Algal cells on the slide were permeabilized by submerging
them in cold 100% ethanol at 220uC for 10 min. Cells were then
washed with PBS containing 0.25 M NaCl at room temperature
for 10 min, followed by PBS for 5 min. After brief washings with
PBS containing 0.5% triton X-100 (PBST), incubation with freshly
diluted rabbit CrPLC antiserum (1:125 dilutions) or preimmune
serum was carried out overnight at 4uC. Samples were incubated
with FITC conjugated anti-rabbit IgG secondary antibody.
Followed by brief washings, coverslips were mounted on slides
applying antifade reagent (Slow Fade Gold, Molecular Probes).
Slides were visualized by Leica TCS SP5 confocal microscope at
central instrument facility, University of Delhi South Campus.
Plasma membrane was labeled by tracker dye FM 4-64
(Invitrogen) at concentration 5 mg/ml.
Lipid Overlay Assay
Lipid overlay assay was conducted using commercial PIP strips
membranes (Molecular probes) [15] with spotted blots of synthetic
phospholipids. Membrane was blocked with 1% skimmed milk in
PBS buffer supplemented with 0.1% tween-20 for 1 hour at room
temperature. The membrane was then incubated overnight on
rocker with 2 mg/ml of recombinant CrPLC protein dissolved in
PBST buffer, washed three times with PBST buffer for 10 min.
Bound protein was then detected by standard immunoblotting as
discussed earlier. Densitometry of blots was performed by Image J
software (http://www.macbiophotonics.ca/imagej).
CD Spectroscopy
Affinity purified CrPLC WT and C7A mutant were further
purified by size exclusion chromatography against 10 mM Sodium
Phosphate buffer pH 7.4. All the Far UV-CD measurements were
performed in Jasco J815 spectrophotometer using quartz cuvette
with the path length of 0.1 cm at room temperature. Spectra of
each protein for protein concentration 0.2 mg/ml were recorded
between 190–260 nm with the 1 nm band width and scan speed of
50 nm/min. Each spectrum was averaged over three scans and
corrected by subtracting buffer baseline. The fractional a-helical,
b-sheet, turns and random coil content of CrPLC WT and mutant
protein was calculated using Rausseans et al method [31].
Supporting Information
Figure S1 Phylogenetic analysis of CrPLC. Phylogenetic
analysis comparing C. reinhardtii phospholipase C (CrPLC) with
other PLC isoforms including sequences (accession numbers are
given in brackets): Homo sapiens (AAH10668.2), Mus Musculus
(CAM22088.1), Catfish (AAA87954.1), Zea Mays (ACG25330.1),
Oryza sativa (ABA98951.2), Nicotiana tabacum (ABP57375.1), Dro-
sophila melanogaster (ACZ95198.1), Arabidopsis thaliana
(AAN75042.1), Ostreococcus lucimarinus (XP_003080695.1). The
number at each branch point represents the bootstrap probability.
(TIF)
Figure S2 Predicted tertiary structure of wild type
CrPLC. (A) Cartoon representation of the 3D structure of the
CrPLC modeled using automated Swiss model server. (B) Position
of aromatic amino acid and cysteine residues present on the
surface of the molecule are shown in blue and red respectively.
(TIF)
Figure S3 SDS-PAGE analysis of recombinant CrPLC.
Purification profile of the recombinant CrPLC purified by
immobilized metal affinity chromatography and resolved on
10% SDS-PAGE.
(TIF)
Figure S4 Immunoblot analysis of dimer and monomer
fractions of CrPLC. Separated monomer and dimer fractions
purified by size exclusion chromatography corresponding to
elution volume 67–76 ml and 79–88 ml respectively immuno-
blotted with CrPLC specific antibody.
(TIF)
Figure S5 Immunoblot analysis of monomer and dimer
fractions of wild type and various mutants of CrPLC
under reducing and non-reducing conditions. (A–E)
Immunoblotting of both dimer (right panel) and monomer elution
fractions (left panel) of CrPLC wild type and mutants under
reducing (+DTT) and non-reducing (2DTT) conditions with
CrPLC specific antibody.
(TIF)
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